Rice Hall James & Associates LLC cut its position in ICU Medical Inc. (NASDAQ:ICUI) by 0.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,965 shares of the company’s stock after selling 24 shares during the period. Rice Hall James & Associates LLC’s holdings in ICU Medical were worth $334,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the company. Bank of Montreal Can bought a new stake in ICU Medical during the second quarter worth about $133,000. Diversified Trust Co bought a new stake in ICU Medical during the second quarter worth about $237,000. M&T Bank Corp raised its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares during the period. Bayesian Capital Management LP raised its stake in ICU Medical by 0.3% in the first quarter. Bayesian Capital Management LP now owns 2,150 shares of the company’s stock worth $224,000 after buying an additional 7 shares during the period. Finally, Checchi Capital Advisers LLC bought a new stake in ICU Medical during the second quarter worth about $242,000. Institutional investors own 89.52% of the company’s stock.
Shares of ICU Medical Inc. (NASDAQ:ICUI) traded up 0.21% on Monday, hitting $149.97. The stock had a trading volume of 255,279 shares. The stock has a market cap of $2.42 billion, a P/E ratio of 44.66 and a beta of 0.37. The firm’s 50-day moving average is $126.14 and its 200 day moving average is $112.44. ICU Medical Inc. has a 1-year low of $85.56 and a 1-year high of $152.67.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Monday, August 8th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.10. The firm earned $96.70 million during the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.97 earnings per share. Equities analysts forecast that ICU Medical Inc. will post $4.54 EPS for the current year.
A number of equities research analysts have weighed in on the company. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $141.00 price objective for the company in a research note on Wednesday, September 21st. Piper Jaffray Cos. restated a “neutral” rating and set a $119.00 price objective (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.
In other ICU Medical news, Director Richard Md Sherman sold 1,500 shares of the business’s stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $140.60, for a total value of $210,900.00. Following the completion of the sale, the director now owns 70,699 shares of the company’s stock, valued at $9,940,279.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Steven Riggs sold 44,739 shares of the business’s stock in a transaction dated Tuesday, September 13th. The stock was sold at an average price of $121.78, for a total value of $5,448,315.42. Following the completion of the sale, the vice president now directly owns 675 shares of the company’s stock, valued at approximately $82,201.50. The disclosure for this sale can be found here. Corporate insiders own 15.90% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.